Prevalence and epidemiology of onychomycosis in patients visiting physicians’ offices: A multicenter Canadian survey of 15,000 patients-Reference-Cited by-同舟云学术

Prevalence and epidemiology of onychomycosis in patients visiting physicians’ offices: A multicenter Canadian survey of 15,000 patients

Published:2000-08 Issue:2 Volume:43 Page:244-248
ISSN:0190-9622
Container-title:Journal of the American Academy of Dermatology
language:en
Short-container-title:Journal of the American Academy of Dermatology

Author:

Gupta Aditya K.,Jain Hem C.,Lynde Charles W.,MacDonald Paul,Cooper Elizabeth A.,Summerbell Richard C.

Publisher

Elsevier BV

Subject

Dermatology

Reference11 articles.

1. Onychomycosis in the laboratory;Achten;Mykosen,1987

2. Antifungals: an overview. Part I;Gupta;J Am Acad Dermatol,1994

3. Antifungals: an overview. Part II;Gupta;J Am Acad Dermatol,1994

4. Prevalence of onychomycosis in patients attending a dermatology clinic in northeastern Ohio for other conditions;Elewski;Arch Dermatol,1997

5. Ghannoum MA, Hajjeh R, Elewski B, et al. Onychomycosis in North America: prevalence, causative organisms, and antifungal susceptibility patterns. J Am Acad Dermatol In press.

Cited by 311 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Systemic absorption and safety of topical terbinafine hydrochloride 10% solution (MOB015B): a phase 1 maximal usage trial in patients with moderate-to-severe onychomycosis;Antimicrobial Agents and Chemotherapy;2024-08-19

2. Treatments for Onychomycosis: A Bibliometric Analysis;Skin Appendage Disorders;2024-07-20

3. Potential emergence of terbinafine resistance by squalene epoxidase gene mutations: An 18‐month cohort study of onychomycosis patients in the United States;Mycoses;2024-07

4. Safety and efficacy of new generation azole antifungals in the management of recalcitrant superficial fungal infections and onychomycosis;Expert Review of Anti-infective Therapy;2024-06-02

5. Antidermatophyte activity and PK/PD of ME1111 in a guinea pig model of tinea corporis;The Journal of Antibiotics;2024-05-20